{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:38:46Z","timestamp":1778895526428,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00108-019-0559-x","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T05:18:51Z","timestamp":1548998331000},"page":"304-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kardiomyopathie bei einem 22-J\u00e4hrigen mit langj\u00e4hrigem Methamphetaminkonsum","Cardiomyopathy in a 22-year-old man with a long history of methamphetamine abuse"],"prefix":"10.1007","volume":"60","author":[{"given":"D. M.","family":"Schwab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. W.","family":"Raake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"559_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.recesp.2017.12.014","volume":"71","author":"H Baumgartner","year":"2018","unstructured":"Baumgartner H, Falk V, Bax JJ et\u00a0al (2018) 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Rev Esp Cardiol 71:67\u201373","journal-title":"Rev Esp Cardiol"},{"key":"559_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","volume":"47","author":"AE Fleckenstein","year":"2007","unstructured":"Fleckenstein AE, Volz TJ, Riddle EL et\u00a0al (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681\u2013698","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"559_CR3","volume-title":"Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users","author":"S Kaye","year":"2005","unstructured":"Kaye S, Mcketin R (2005) Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users. National Drug and Alcohol Research Centre, Sydney"},{"key":"559_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1532-429X-11-46","volume":"11","author":"JE Lopez","year":"2009","unstructured":"Lopez JE, Yeo K, Caputo G et\u00a0al (2009) Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. J\u00a0Cardiovasc Magn Reson 11:46","journal-title":"J Cardiovasc Magn Reson"},{"key":"559_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.hlc.2015.10.019","volume":"25","author":"ED Paratz","year":"2016","unstructured":"Paratz ED, Cunningham NJ, Macisaac AI (2016) The cardiac complications of methamphetamines. Heart Lung Circ 25:325\u2013332","journal-title":"Heart Lung Circ"},{"key":"559_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0379-0738(79)90288-3","volume":"13","author":"J Rajs","year":"1979","unstructured":"Rajs J, Falconer B (1979) Cardiac lesions in intravenous drug addicts. Forensic Sci Int 13:193\u2013209","journal-title":"Forensic Sci Int"},{"key":"559_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jchf.2017.02.017","volume":"5","author":"S Schurer","year":"2017","unstructured":"Schurer S, Klingel K, Sandri M et al (2017) Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy. JACC Heart Fail 5:435\u2013445","journal-title":"JACC Heart Fail"},{"key":"559_CR8","volume-title":"World drug report","author":"Unodc","year":"2017","unstructured":"Unodc (2017) World drug report"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0559-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0559-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0559-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T19:10:20Z","timestamp":1580497820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0559-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0559-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"1 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.M.\u00a0Schwab, H.A. Katus und P.W. Raake geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine vom Autor durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}